Maryann Stephenson
Family · Ashland, KYNPI 1154696912
Payments from drug & device makers
Across 171 payments — averaging $15.89 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- AbbVie$855
- Salix Pharmaceuticals, A Division Of Bausch Health US, LLC$377
- GSK$186
- Pfizer$141
- Novo Nordisk$123
- Amarin Pharma, Inc.$103
- plus $931 from 24 others
What the payments were for
- Food & beverage$2,716100%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| AbbVie | 61 | $855 |
| Salix Pharmaceuticals, A Division Of Bausch Health US, LLC | 24 | $377 |
| GSK | 10 | $186 |
| Pfizer | 9 | $141 |
| Novo Nordisk | 7 | $123 |
| Amarin Pharma, Inc. | 6 | $103 |
| Merck | 6 | $89 |
| Abbott | 5 | $82 |
| Vanda Pharmaceuticals Inc. | 4 | $82 |
| Supernus Pharmaceuticals, Inc. | 3 | $63 |
| Biohaven Pharmaceutical Holding Company Ltd. | 3 | $50 |
| Otsuka America Pharmaceutical, Inc. | 2 | $46 |
| Teva Pharmaceuticals USA, Inc. | 2 | $44 |
| Boehringer Ingelheim | 3 | $44 |
| Mylan Specialty L.p. | 2 | $41 |
| Exact Sciences | 2 | $38 |
| Amgen | 2 | $37 |
| Alkermes, Inc. | 2 | $36 |
| AstraZeneca(2 entities) | 2 | $32 |
| Biohaven Pharmaceuticals, Inc. | 2 | $32 |
| Antares Pharma, Inc. | 2 | $31 |
| Indivior Inc. | 2 | $29 |
| Lilly USA, LLC | 2 | $29 |
| Bayer | 2 | $29 |
| Taiho Oncology, Inc. | 1 | $25 |
| Esperion Therapeutics, Inc. | 1 | $16 |
| Daiichi Sankyo Inc. | 1 | $15 |
| Lundbeck LLC | 1 | $15 |
| Takeda Pharmaceuticals U.S.A., Inc. | 1 | $15 |
| Dexcom, Inc. | 1 | $12 |
How this compares
$2,716 in reported general payments places this provider in the 80th percentile of 4,374 family providers in Kentucky.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| OzempicSemaglutide | 82 | $77,070 |
| JardianceEmpagliflozin | 55 | $57,588 |
| LinzessLinaclotide | 61 | $54,192 |
| EliquisApixaban | 98 | $50,490 |
| Trelegy ElliptaFluticasone/Umeclidin/Vilanter | 38 | $45,348 |
| VraylarCariprazine Hcl | 48 | $41,753 |
| FarxigaDapagliflozin Propanediol | 25 | $27,861 |
| JanuviaSitagliptin Phosphate | 29 | $26,030 |
| TrulicityDulaglutide | 11 | $25,262 |
| Repatha SureclickEvolocumab | 23 | $21,749 |
| XareltoRivaroxaban | 13 | $18,319 |
| Toujeo SolostarInsulin Glargine,hum.Rec.Anlog | 22 | $15,772 |
| Nurtec OdtRimegepant Sulfate | 15 | $14,894 |
| VascepaIcosapent Ethyl | 19 | $10,356 |
| Breo ElliptaFluticasone/Vilanterol | 12 | $7,202 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| AbbVieLinzess, Vraylar, Synthroid | $855 | $97,580149 claims |
| Novo NordiskOzempic | $123 | $77,07082 claims |
| PfizerEliquis, Nurtec Odt | $141 | $65,385113 claims |
| Boehringer IngelheimJardiance | $44 | $57,58855 claims |
| GSKTrelegy Ellipta, Breo Ellipta | $186 | $52,55050 claims |
| AstraZenecaFarxiga, Symbicort | $32 | $34,13740 claims |
| MerckJanuvia | $89 | $26,03029 claims |
| Lilly USA, LLCTrulicity | $29 | $25,26211 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 80th percentile of 4,374 family providers in Kentucky.
Other family in Ashland
- Ashley MaloneAshland$14K
- Bonnie HillLouisa$372K
- Ashley SnellenElizabethtown$190K
- Smita RanjanLouisville$92K
- Elizabeth SaltLexington$89K
- Tracey GaslinLouisville$79K
- Kassandra GreenLouisville$69K
- Danielle RevertLouisville$65K
- Lora BrownMonticellow$61K
- Shelley WaldmanLouisville$59K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.